UnitedHealth Group expects Optum to see a long-term double-digit revenue growth rate and bring in a range between $212 billion to $214 billion in 2023 revenues.
The Minnetonka, Minn.-based healthcare giant shared Nov. 29 it projects growth margins of over 20 percent for technology products and low- to mid-single-digit growth for pharmacy care services.
2023 projections:
Optum Health
Revenues: $91 billion to $92 billion
Earnings: $7.4 billion to $7.6 billion
Optum Insight
Revenues: $18.6 billion to $19.3 billion
Earnings: $4.4 billion to $4.5 billion
OptumRx
Revenues: $105.5 billion to $106.5 billion
Earnings: $4.8 billion to $4.9 billion
UnitedHealth Group expects 2023 revenues of $357 billion to $360 billion, net earnings of $23.15 to $23.65 per share, and adjusted net earnings of $24.40 to $24.90 per share. Cash flows from operations are expected to be $27 billion to $28 billion.
UnitedHealthcare expects 2023 revenues to range from $274 billion to $276 billion. By the end of this year, the payer's revenues are expected to hit $249.2 billion, up from $222.9 billion in 2021.